CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The HEAD-P project focuses on deprescribing, aiming to reduce unnecessary medications and associated risks. It investigates adverse drug withdrawal events through systematic reviews, data analysis, and interviews to enhance pharmacovigilance practices and improve patient safety in healthcare systems.
Deprescribing (reducing or stopping unnecessary or harmful medications) is an important strategy to reduce the risk of medication harm – a significant and growing challenge for health systems as acknowledged by the World Health Organization.
The aim of HEAD-P is to establish the current evidence base on adverse drug withdrawal events (ADWEs) and explore how this can be enhanced via the pharmacovigilance system. HEAD-P consists of 4 research objectives: to assess the rate of ADWEs in published tr…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
